BSX

Boston Scientific Corporation

HealthcareMedical DevicesNASDAQ

$48.31

-$7.47 (-15.47%)today

Conviction

0/ 10

Fair Value$100.31

Upside+107.64%

Signal0

Market Cap$91.1B

52W Range$60.90–$109.50

Next EarningsApr 22

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$71.73

Current Price$69.17

Upside / Down+3.7%

P(Undervalued)56.4%

P(20%+ Up)25.4%

P(15%+ Down)20.6%

Fair Value Distribution — percentile bands

56.4% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

12.6%/yr

±5.4% · revenue growth to justify current price

FCF-Based Reverse DCF

13.7%/yr

±3.4% · FCF growth to justify current price

THE GAP

Market pricing margin compression or rising capex

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Quick Take

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

Trailing P/E31.6x

Forward P/E15.7x

P/S4.5x

EPS (TTM)$1.94

Analyst Target$100.31

Analyst Upside107.6%

No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10kMar 1

Conviction: unchanged

BSX FY2025 10-K: FARAPULSE Dominates, Penumbra Overhang Looms

Boston Scientific delivered exceptional FY2025 results — .1B revenue (+19.9% reported, +15.8% organic), driven overwhelmingly by FARAPULSE PFA System dominating the atrial fibrillation EP market. Adju...